Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of KTZ-S 2% in seborrhoeic dermatitis of the scalp
jRCT2031230597Phase 3Completed
- Sponsor
- SEREN Pharmaceuticals
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoconazole in seborrheic dermatitis (SD) (3 arms), sponsored by SEREN Pharmaceuticals. Started Feb 2024; status: completed.
02
Drugs
ketoconazole
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on jRCT2031230597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230597.